Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
February 8, 2011
Patent Application Number
12615477
Date Filed
November 10, 2009
Patent Citations Received
Patent Primary Examiner
Patent abstract
A composition and method of treating adrenergic dysregulation by administering the composition is disclosed, wherein the composition comprises a a2-adrenergic receptor agonist; a pharmaceutically acceptable hydrophilic matrix and a release-retardant of a metal alkyl sulfate. In embodiments, the composition provides a sustained release of the agonist, wherein after administration of the composition no more than once about every 12 hours to a subject having a steady state plasma concentration of the a2-adrenergic receptor agonist, the agonist's plasma concentration peak-to-trough ratio is no greater than about 1.9.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
